The first trial of an experimental Ebola vaccine in Africa has shown it is safe for use, scientists say. “This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population,” said lead author Dr Julie Ledgerwood from the National Institutes of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health, US.
You are here: / / Ebola vaccine safe for use in Africa: Study
This site uses Akismet to reduce spam. Learn how your comment data is processed.